C-type Natriuretic Peptide: A novel biomarker of steroid induced bone toxicity in children with acute lymphoblastic leukemia (ALL)

Peptides

Volumn 36, Issue 1, 2012, Pages 54-59

  Prickett, Timothy C R ^a   Lyver, Amanda ^a   Wilson, Rachel ^a   Espiner, Eric A ^a   Sullivan, Michael J ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Dexamethasone; Growth velocity; Linear growth; NTproCNP; Steroids

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; AMINO TERMINAL PRO NATRIURETIC PEPTIDE C; ASPARAGINASE MACROGOL; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; MERCAPTOPURINE; METHOTREXATE; NATRIURETIC FACTOR; NATRIURETIC PEPTIDE TYPE C; PREDNISOLONE; UNCLASSIFIED DRUG; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BODY HEIGHT; BONE GROWTH; BONE TURNOVER; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; ENCHONDRAL OSSIFICATION; FEMALE; HUMAN; MAINTENANCE THERAPY; MALE; MULTIPLE CYCLE TREATMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; SCHOOL CHILD; SIDE EFFECT; SINGLE DRUG DOSE; TREATMENT RESPONSE;

ALKALINE PHOSPHATASE; ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; BODY HEIGHT; BONE AND BONES; BONE DEVELOPMENT; CHILD; CHILD, PRESCHOOL; COLLAGEN; DEXAMETHASONE; GLUCOCORTICOIDS; HUMANS; INDUCTION CHEMOTHERAPY; MAINTENANCE CHEMOTHERAPY; NATRIURETIC PEPTIDE, C-TYPE; PEPTIDE FRAGMENTS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREDNISOLONE; PROSPECTIVE STUDIES;

RODENTIA;

EID: 84862135019     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2012.04.017     Document Type: Article

References (30)

1. C.F. Bartels, H. Bukulmez, P. Padayatti, D.K. Rhee, C. van Ravenswaaij-Arts, and R.M. Pauli Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux Am J Hum Genet 75 2004 27 34
2. R. Bocciardi, R. Giorda, J. Buttgereit, S. Gimelli, M.T. Divizia, and S. Beri Overexpression of the C-type natriuretic peptide (CNP) is associated with overgrowth and bone anomalies in an individual with balanced t(2;7) translocation Hum Mutat 28 2007 724 731
3. H. Chusho, N. Tamura, Y. Ogawa, A. Yasoda, M. Suda, and T. Miyazawa Dwarfism and early death in mice lacking C-type natriuretic peptide Proc Natl Acad Sci U S A 98 2001 4016 4021
4. P.M. Crofton, S.F. Ahmed, J.C. Wade, R. Stephen, M.W. Elmlinger, and M.B. Ranke Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia J Clin Endocrinol Metab 83 1998 3121 3129
5. V.K. Dalton, M. Rue, L.B. Silverman, R.D. Gelber, B.L. Asselin, and R.D. Barr Height and weight in children treated for acute lymphoblastic leukemia: relationship to CNS treatment J Clin Oncol 21 2003 2953 2960
6. H. Lango Allen, K. Estrada, G. Lettre, S.I. Berndt, M.N. Weedon, and F. Rivadeneira Hundreds of variants clustered in genomic loci and biological pathways affect human height Nature 467 2010 832 838
7. A. Moncla, C. Missirian, P. Cacciagli, E. Balzamo, L. Legeai-Mallet, and J.L. Jouve A cluster of translocation breakpoints in 2q37 is associated with overexpression of NPPC in patients with a similar overgrowth phenotype Hum Mutat 28 2007 1183 1188
8. R.C. Olney C-type natriuretic peptide in growth: a new paradigm Growth Horm IGF Res 16 Suppl. A 2006 S6 S14
9. R.C. Olney Mechanisms of impaired growth: effect of steroids on bone and cartilage Horm Res 72 Suppl. 1 2009 30 35
10. R.C. Olney, T.C. Prickett, T.G. Yandle, E.A. Espiner, J.C. Han, and N. Mauras Amino-terminal propeptide of C-type natriuretic peptide and linear growth in children: effects of puberty, testosterone and growth hormone J Clin Endocrinol Metab 92 2007 4294 4298
11. K.M. Parmar, H.B. Larman, G. Dai, Y. Zhang, E.T. Wang, and S.N. Moorthy Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2 J Clin Invest 116 2006 49 58
12. L.R. Potter Natriuretic peptide metabolism, clearance and degradation FEBS J 278 2011 1808 1817
13. L.R. Potter, S. Abbey-Hosch, and D.M. Dickey Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions Endocr Rev 27 2006 47 72
14. A. Prader, R.H. Largo, L. Molinari, and C. Issler Physical growth of Swiss children from birth to 20 years of age first Zurich longitudinal study of growth and development Helv Paediatr Acta Suppl 52 1989 1 125
15. T.C. Prickett, C.J. Charles, T.G. Yandle, A.M. Richards, and E.A. Espiner Skeletal contributions to plasma CNP forms: evidence from regional sampling in growing lambs Peptides 30 2009 2343 2347
16. T.C. Prickett, B. Dixon, C. Frampton, T.G. Yandle, A.M. Richards, and E.A. Espiner Plasma amino-terminal pro C-type natriuretic peptide in the neonate: relation to gestational age and postnatal linear growth J Clin Endocrinol Metab 93 2008 225 232
17. T.C.R. Prickett, and E.A. Espiner C-type natriuretic peptide (CNP) and postnatal linear growth V.R. Preedy, Handbook of growth and growth monitoring in health and disease 2012 Springer 2789 2809
18. T.C.R. Prickett, A.M. Lynn, G.K. Barrell, B.A. Darlow, V.A. Cameron, and E.A. Espiner Amino-terminal proCNP: a putative marker of cartilage activity in postnatal growth Pediatr Res 58 2005 334 340
19. T.C.R. Prickett, T.G. Yandle, M.G. Nicholls, E.A. Espiner, and A.M. Richards Identification of amino-terminal pro-C-type natriuretic peptide in human plasma Biochem Biophys Res Commun 286 2001 513 517
20. M. Rauchenzauner, A. Schmid, P. Heinz-Erian, K. Kapelari, G. Falkensammer, and A. Griesmacher Sex- and age-specific reference curves for serum markers of bone turnover in healthy children from 2 months to 18 years J Clin Endocrinol Metab 92 2007 443 449
21. C.S. Reh, R. Olney, C. Azen, T. Prickett, E. Espiner, and M. Geffner Plasma CNP forms and thyroid status in prepubertal children with acquired thyroid disease Clin Endocrinol (Oxf) 76 2012 228 235
22. B.J. Schouten, T.C. Prickett, A.A. Hooper, G.J. Hooper, T.G. Yandle, and A.M. Richards Central and peripheral forms of C-type natriuretic peptide (CNP): evidence for differential regulation in plasma and cerebrospinal fluid Peptides 32 2011 797 804
23. T. Siebler, H. Robson, S.M. Shalet, and G.R. Williams Dexamethasone inhibits and thyroid hormone promotes differentiation of mouse chondrogenic ATDC5 cells Bone 31 2002 457 464
24. G.S. Stein, J.B. Lian, and T.A. Owen Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation FASEB J 4 1990 3111 3123
25. S. Suga, K. Nakao, H. Itoh, Y. Komatsu, Y. Ogawa, and N. Hama Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of vascular natriuretic peptide system J Clin Invest 90 1992 1145 1149
26. P. Szulc, E. Seeman, and P.D. Delmas Biochemical measurements of bone turnover in children and adolescents Osteoporos Int 11 2000 281 294
27. M.B. Viana, and M.I. Vilela Height deficit during and many years after treatment for acute lymphoblastic leukemia in children: a review Pediatr Blood Cancer 50 2008 509 517
28. C. Wu, F. Wu, J. Pan, J. Morser, and Q. Wu Furin-mediated processing of pro-C-type natriuretic peptide J Biol Chem 278 2003 25847 25852
29. T.G. Yandle, S. Fisher, C. Charles, E.A. Espiner, and A.M. Richards The ovine hypothalamus and pituitary have markedly different distributions of C-type natriuretic peptide forms Peptides 14 1993 713 716
30. Z. Zhao, and L. Ma Regulation of axonal development by natriuretic peptide hormones Proc Natl Acad Sci U S A 106 2009 18016 18021